This is the principle behind a new analgesic method called light-induced analgesia (LIA), discovered by scientists from the ...
Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to new research published in Science ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
A salivary miRNA test for endometriosis shows high accuracy; however, experts debate whether it can replace laparoscopy.
Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...
Kratom and synthetic alternative drugs are not to be possessed or sold within the city of Bloomington, according to a new ...
The Global Central Nervous System Therapeutics Market is poised for growth driven by an aging population and heightened mental health awareness. Opportunities include disease-modifying biologics and ...
Dagens.com on MSN
New painkiller could be the beginning of the end for opioids
A study has shown that unlike opioids like morphine, the experimental painkiller does not cause tolerance, meaning you don't ...
Choshen-Hillel’s research explores how people make decisions, which biases shape their choices, and how fairness and honesty influence behavior. “Decision-making is the foundation of human behavior,” ...
A new class of Alzheimer’s drugs has been shown to slow the condition’s progression by removing clumps of protein known as amyloid plaques from the brain. However, few countries have approved use of ...
Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the US Food and Drug Administration (FDA) has accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results